Home > Organization > Division of Supportive Care Research(Tsukiji) > Research Summary
Research Summary
- Support of projects regarding innovation of novel compounds in supportive and palliative care fields
- First-in-human, second and third clinical trials to develop a novel analgesic for oral mucositis in cancer patients
- Development of novel compounds for the inhibition of platelet-activating factor (PAF) signaling loop, the pathway causing progression of severe chronic pain
- Development of novel and specific agonists for μ/δ opioid hetero-dimerized receptors
- Development of compounds for the improvement of cancer cachexic symptoms: clinical application of ghrelin and des-acyl ghrelin for the inhibition of cardiac intoxication from chemotherapy and/or cancer cachexia
- Research of Japanese kampo medicines to improve (QOL) in cancer patients